Melanoma, a highly malignant tumor arising from melanocytes, is the most common life-threatening dermatological disease. Risk factors include UV radiation exposure, particularly in light-skinned individuals that are easily sunburned, increasing age, family history, and immunosuppression. The superficial spreading melanoma is the most common subtype. Other subtypes, such as nodular melanoma, have a significantly worse prognosis because they tend to metastasize more rapidly. Invasive melanoma is particular in its propensity to metastasize to unusual locations that are not commonly affected by other malignancies. Immediate full-thickness surgical biopsy of the primary tumor is usually the best initial diagnostic test and may be therapeutic for localized disease. Chemotherapy, biologics, and/or radiation therapy are recommended for recurrent or widespread disease. Tumor thickness is the most important prognostic factor.
Most common life-threatening dermatological disease
Epidemiological data refers to the US, unless otherwise specified.
- UV radiation exposure
- Light skin
- Dysplastic nevi , giant congenital nevi, or inherited skin conditions (e.g., dysplastic nevus syndrome, familial atypical mole, melanoma syndrome, xeroderma pigmentosa)
- Genetics 
- Pruritic, persistently bleeding skin lesion
Dermoscopy should be used to examine lesions for ABCDE criteria:
- A = Asymmetry
- B = Border (irregular border with indistinct margins)
- C = Color (new changes in pigmentation or variations in pigmentation within the same lesion)
- D = Diameter > 6 mm
- E = Evolving (new lesion or a lesion that changes in size, shape, or color over time)
Types of melanoma
|Overview of melanoma types |
|Frequency and characteristic features||Predilection sites||Clinical appearance||Growth|
Superficial spreading melanoma
| || || || |
| || || |
Lentigo maligna melanoma
| || || || |
Acral lentiginous melanoma
| || || |
Subtypes and variants
Genitourinary melanoma (GU melanoma)
- Rare (< 5%)
- Approx. 45% of all mucosal melanomas
- Most commonly affects female individuals (approx. 90%)
- Cause remains unknown.
- Expression of cell biomarkers such as PD-1 and PD-L1 in vulvar melanoma is significantly higher than in cutaneous melanomas.
- Prognosis is generally poor.
Types of GU melanoma 
|Overview of GU melanoma types|
|Characteristics||Female genital melanoma||Male genital melanoma||Urological mucosal melanoma|
|Epidemiology|| || |
|Classification|| || |
|Treatment|| || || |
- Pink or skin-colored nodes ; may be difficult to recognize
- Histological diagnosis is necessary
- A full-thickness excisional biopsy (best diagnostic test) with 1–3 mm margins is indicated in all suspicious lesions. ; 
- Staging tests (e.g., ultrasound or MRI) once diagnosis confirmed: to determine tumor thickness, spread to lymph nodes, or distant metastasis 
|Differential diagnosis of common skin cancers|
|Color||Morphology||Location||Other characteristic features|
|Melanoma|| || || || |
| || || |
| || || || |
Benign lesions commonly resemble melanomas and should be biopsied to rule out cancer (see “”).
The differential diagnoses listed here are not exhaustive.
- Surgical excision: full-thickness excision with appropriate safety margins
|Breslow classification of invasive melanoma|
|Breslow stage||TNM stage||Modified by AJCC||Safety margin|
|I||pT1||≤ 1.0 mm||1 cm|
|II||pT2||1.01–2 mm||1–2 cm|
|III||pT3||2.01–4 mm||2 cm|
|IV||pT4||≥ 4 mm|
|If tumor thickness > 1 mm (Breslow stage ≥ II): perform sentinel lymph node biopsy|
- BRAF kinase inhibitor (e.g., vemurafenib) is used in metastatic or unresectable melanomas that have the BRAF V600E mutation (substitution of glutamic acid in place of valine at amino acid position 600 caused by activating mutations in the BRAF gene) 
- Immunotherapy: checkpoint inhibitors (e.g., pembrolizumab, nivolumab) for tumors positive for PD-1 mutations 
The gold standard is immediate, complete excision of the tumor.
Metastatic disease 
- Metastatic melanoma may spread to lymph nodes, liver, lung, brain, and bone
- May also metastasize to locations not typically affected by metastatic malignancies 
- Up to 5% of metastatic cases have no known primary tumor.
- Characteristic black pigmentation
We list the most important complications. The selection is not exhaustive.
Negative prognostic factors
- Epidemiological features: male sex
- Clinical features: type , localization , and presence of ulcerations
- Melanoma has a significant risk of metastasis, which is associated with a poorer prognosis.
- Tumor thickness, as determined from the Breslow thickness, is the most important prognostic factor.